Stock Details
KDSKF is Koninklijke DSM N.V.'s stock. Stock exchange Other OTC (Currency USD). Average price in 50 days is 127.67$. Average daily volumn in 3 months 8.78k. Market cap 21.81B



Stock symbol : KDSKF. Exchange : Other OTC. Currency : USD
Lastest price : 124.00$. Total volume : 995.00. Market state PRE
Click reload if you want to check the lastest price on market!!!

Koninklijke DSM N.V. (KDSKF)
Last Price
124.00$
Change
-1.89
Volume
995.00

Previous Close125.89
Open125.95
Day Range124.00-127.50
Bid0.00 x N/A
Ask0.00 x N/A
Volume995
Average Volume8.78k
Market Cap21.81B
Beta0.73
52 Week Range104.34-194.25
Trailing P/E18.48
Foward P/E18.67
Dividend (Yield %)2.22%
Ex-Dividend Date2022-08-04



Financial Details


According to Koninklijke DSM N.V.'s financial reports the company's revenue in 2021 were 9.2B an increase( +12.5%) over the years 2020 revenue that were of 8.11B. In 2021 the company's total earnings were 1.68B while total earnings in 2020 were 506M( +97.63%).


Loading ...



Organization

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vit... amins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Market Cap:
21.81B
Revenue:
9.2B
Total Assets:
16.01B
Total Cash:
1.56B


News about "Koninklijke DSM N.V."

DSM - delivery of shares

Source from : YAHOO!Finance - 1 days ago

Following the Offering Circular published on 22 November 2022, Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer ...See details»


Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Source from : Yahoo - 1 month ago

It is hard to get excited after looking at Koninklijke DSM's (AMS:DSM) recent performance, when its stock has declined 3.0% over the past month. However, the company's fundamentals look pretty ...See details»


Koninklijke DSM N.V.

Source from : Wall Street Journal - 18 days ago

1 Day KDSKF 0.17% DJIA 0.33% S&P 500 0.40% Basic Materials/Resources 0.39% Thomas Leysen Chairman-Supervisory Board Koninklijke DSM NV, Mediahuis Partners NV, Mediacore NV, Tradicor NV ...See details»


Koninklijke DSM NV ADR Stock (OTC:RDSMY), Short Interest Report

Source from : Benzinga.com - 7 month ago

Short interest for Koninklijke DSM NV ADR gives investors a sense of the degree to which investors are betting on the decline of Koninklijke DSM NV ADR's stock. Short interest data is updated ...See details»


Koninklijke DSM NV ADR Stock (OTC:RDSMY), Key Statistics

Source from : Benzinga.com - 7 month ago

Koninklijke DSM NV ADR Stock (OTC: RDSMY) analysis, key statistics. Koninklijke DSM NV ADR Stock (OTC: RDSMY) analysis, key statistics. Koninklijke DSM NV ADR Stock (OTC: RDSMY) analysis ...See details»


WITH CRYPTO MARKETS IN TURMOIL, THE BLOCK LAUNCHES NEW TOOLS FOR INDUSTRY

Source from : Le Lรฉzard - 1 days ago

This is a press release by Koninklijke DSM N.V. (Royal DSM), pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) ...See details»


acceptance-period-for-exchange-offer-extended-pending-competition-clearances-image

ACCEPTANCE PERIOD FOR EXCHANGE OFFER EXTENDED PENDING COMPETITION CLEARANCES

Source from : Asia One - 8 days ago

THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE ...See details»


EPA and DHA Market Growth Analysis, Development Prospects and Business Improvement Factors by 2030 | Koninklijke DSM NV, KD Pharma Group

Source from : Digital Journal - 15 days ago

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known ...See details»


Eubiotics Market To See Strong Growth by 2030 | Cargill, Koninklijke DSM, Novozymes

Source from : Digital Journal - 1 month ago

Allied Market Research Analyst have added a new research study on Title Eubiotics Market, Global Outlook and Forecast 2022-2030 with detailed information & Key Players Such as Cargill ...See details»


DSM - delivery of shares

Source from : Yahoo Finance - 3 days ago

This is a press release by Koninklijke DSM N.V. (Royal DSM), pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen ...See details»


Koninklijke DSM N.V.

Source from : Wall Street Journal - 11 days ago

1 Day DSM 2.38% DJIA 1.00% S&P 500 1.89% Basic Materials/Resources 0.66% Thomas Leysen Chairman-Supervisory Board Koninklijke DSM NV, Mediahuis Partners NV, Mediacore NV, Tradicor NV, Rubens House ...See details»


Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Source from : Yahoo News UK - 1 month ago

It is hard to get excited after looking at Koninklijke DSM's (AMS:DSM) recent performance, when its stock has declined 3.0% over the past month. However, the company's fundamentals look pretty decent, ...See details»


Koninklijke DSM N.V.

Source from : Barron's - 1 year ago

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...See details»


Royal DSM: DSM - delivery of shares

Source from : Finanznachrichten - 6 days ago

This is a press release by Koninklijke DSM N.V. (Royal DSM), pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen ...See details»